STANDARD BIOTOOLS INC. (LAB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 20M 40M 60M Q3 '21: 28.5M Q4 '21: 38.3M Q1 '22: 26.5M Q2 '22: 18.8M Q3 '22: 25.6M Q4 '22: 27M Q1 '23: 25.1M Q2 '23: 27.7M Q3 '23: 25.4M Q4 '23: 28.2M Q1 '24: 45.5M Q2 '24: 22.5M Q3 '24: 22.1M Q4 '24: 24.8M Q1 '25: 20.2M Q2 '25: 21.8M Q3 '25: 19.6M Q4 '25: 23.8M Q1 '26: 21.1M Q2 '26: 20.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 9M 18M 27M Q3 '20: 20.8M Q4 '20: 22.1M Q1 '22: 12.2M Q2 '22: 4.4M Q3 '22: 9.2M Q4 '22: 11.2M Q1 '23: 12.3M Q2 '23: 13.6M Q3 '23: 11.2M Q4 '23: 13.4M Q1 '24: 24.2M Q2 '24: 10.4M Q3 '24: 12.1M Q4 '24: 11.4M Q1 '25: 11M Q2 '25: 10.6M Q3 '25: 9.5M Q4 '25: 11.4M Q1 '26: 11.3M Q2 '26: 10.5M Q4 '20 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -19.6M Q4 '21: -11.3M Q1 '22: -27.5M Q2 '22: -38.6M Q3 '22: -29M Q4 '22: -21.1M Q1 '23: -16.6M Q2 '23: -17.4M Q3 '23: -21.2M Q4 '23: -21.4M Q1 '24: -60.2M Q2 '24: -30.3M Q3 '24: -26.7M Q4 '24: -26.1M Q1 '25: -27M Q2 '25: -25.7M Q3 '25: -32.9M Q4 '25: -24.6M Q1 '26: -12.5M Q2 '26: -25.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-100M -50M 0 50M 100M 150M Q3 '21: -13.8M Q4 '21: -9.4M Q1 '22: -76.3M Q2 '22: -63.5M Q3 '22: -29.4M Q4 '22: -20.8M Q1 '23: -16.8M Q2 '23: -17M Q3 '23: -21M Q4 '23: -19.8M Q1 '24: -32.2M Q2 '24: -45.7M Q3 '24: -26.9M Q4 '24: -34.1M Q1 '25: -26M Q2 '25: -33.5M Q3 '25: -34.7M Q4 '25: 19.3M Q1 '26: 127.1M Q2 '26: -26.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 8M 16M 24M Q3 '19: 12.5M Q4 '19: 14.6M Q1 '22: 14.3M Q2 '22: 14.3M Q3 '22: 16.4M Q4 '22: 15.9M Q1 '23: 12.8M Q2 '23: 14.1M Q3 '23: 14.2M Q4 '23: 14.8M Q1 '24: 21.4M Q2 '24: 12.1M Q3 '24: 10M Q4 '24: 13.4M Q1 '25: 9.2M Q2 '25: 11.1M Q3 '25: 10.1M Q4 '25: 12.4M Q1 '26: 9.8M Q2 '26: 9.6M Q4 '19 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -9.5M Q4 '21: -7M Q1 '22: -15.6M Q2 '22: -30M Q3 '22: -24.6M Q4 '22: -19.2M Q1 '23: -8.5M Q2 '23: -9.3M Q3 '23: -11.4M Q4 '23: -14.1M Q1 '24: -62.5M Q2 '24: -39M Q3 '24: -27.9M Q4 '24: -14.1M Q1 '25: -30.3M Q2 '25: -20.7M Q3 '25: -22.2M Q4 '25: -1.2M Q1 '26: -46.6M Q2 '26: -10.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -11.2M Q4 '21: -7.5M Q1 '22: -16.5M Q2 '22: -30.9M Q3 '22: -25.9M Q4 '22: -19.9M Q1 '23: -9.5M Q2 '23: -10.2M Q3 '23: -12.3M Q4 '23: -14.1M Q1 '24: -63.3M Q2 '24: -41M Q3 '24: -30.1M Q4 '24: -17.4M Q1 '25: -35.3M Q2 '25: -22.6M Q3 '25: -23.1M Q4 '25: -1.7M Q1 '26: -47.2M Q2 '26: -10.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '20: 70.9M Q3 '20: 72.5M Q1 '21: 74.7M Q2 '21: 75.5M Q3 '21: 76.3M Q1 '22: 77M Q2 '22: 77.8M Q3 '22: 78.9M Q1 '23: 79.1M Q2 '23: 78.7M Q3 '23: 79.2M Q1 '24: 294.1M Q2 '24: 372.3M Q3 '24: 371.5M Q1 '25: 378.2M Q2 '25: 380.5M Q3 '25: 382.6M Q1 '26: 388.2M Q2 '26: 390.9M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.70 -1.80 -0.90 0.00 0.90 1.80 2.70 Q3 '21: -0.91 Q4 '21: -0.78 Q1 '22: -1.52 Q2 '22: -2.11 Q3 '22: -2.30 Q4 '22: -2.44 Q1 '23: -1.66 Q2 '23: -1.06 Q3 '23: -0.96 Q4 '23: -0.95 Q1 '24: -1.01 Q2 '24: -0.91 Q3 '24: -0.71 Q4 '24: -0.54 Q1 '25: -0.34 Q2 '25: -0.31 Q3 '25: -0.33 Q4 '25: -0.20 Q1 '26: 0.20 Q2 '26: 0.22 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.